NCT00004482View on ClinicalTrials.gov

Phase II Randomized Study of Muromonab-CD3, Cyclosporine, Methylprednisolone, and Prednisone in Patients With Giant Cell Myocarditis

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 31, 1999

Primary Completion Date

July 31, 2005

Study Completion Date

July 31, 2006

Conditions
MyocarditisGiant Cell Myocarditis
Interventions
DRUG

Cyclosporine

DRUG

methylprednisolone

DRUG

Muromonab-CD3

DRUG

prednisone

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER